HyClone covers cell culture, gene modulation and magnetic beads. GE Healthcare officials expect the acquisition will expand its life sciences business.
Terms of the deal were not disclosed. The transaction was first announced in January.
More Articles on GE Healthcare:
GE Healthcare Recalls Infant Resuscitation Systems
GE Healthcare Expands Technology Offerings
New Mississippi Program to Connect Rural Diabetics with Specialists via Telehealth
